Colorectal cancer (CRC) is on the rise in young adults. Incidences of colorectal cancer in young people (those between their mid-20s and late 50s) has more than
Howard S. Hochster, MD, FACP, director of the Gastrointestinal Oncology Program and Rutgers Cancer Institute of New Jersey Associate Director for Clinical Resea
Howard S. Hochster, MD, FACP, director of the Gastrointestinal Oncology Program and Rutgers Cancer Institute of New Jersey Associate Director for Clinical Resea
Colorectal cancer (CRC) is on the rise in young adults. Incidences of colorectal cancer in young people (those between their mid-20s and late 50s) has more than
Howard S. Hochster, MD, discusses the importance of clinical trial participation for patients with cancer and highlights the use of precision medicine across the treatment armamentarium.